Tenet Healthcare (NYSE:THC) Stock Price Up 11.8% Following Strong Earnings

Tenet Healthcare Corporation (NYSE:THC)’s stock price traded up 11.8% during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $216.04 and last traded at $215.90. 897,753 shares traded hands during mid-day trading, a decline of 4% from the average session volume of 933,138 shares. The stock had previously closed at $193.04.

The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.05 by $0.65. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The business’s revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the business posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Trending Headlines about Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 earnings beat and revenue acceleration — Tenet reported $4.70 EPS vs. consensus ~ $4.05 and revenue rose ~8.9% year‑over‑year (~$5.53B), driven by hospital and ambulatory surgery demand. Tenet Healthcare Profit Rises on Ambulatory and Hospital Revenue Growth
• Positive Sentiment: Raised/clear FY‑2026 targets and EBITDA range — Management provided 2026 EPS guidance and an adjusted‑EBITDA target ($4.485B–$4.785B), signaling confidence in continued margin expansion and cash flow. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target
• Positive Sentiment: Management commentary and investor materials emphasize structural cost initiatives and M&A as levers to sustain growth and margins, reinforcing the outlook. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Market reaction — Coverage notes the stock hit record highs and traded on heavy volume after the release, indicating broad investor enthusiasm. Tenet Healthcare stock rises after Q4 beat
• Neutral Sentiment: Full‑year guidance range vs. consensus — Tenet gave an EPS range (16.19–18.47) and revenue range ($21.5B–$22.3B) that broadly brackets analyst expectations; midpoint is roughly close to consensus but leaves room for execution risk. Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook
• Negative Sentiment: Earlier concerns about patient‑day trends — Pre‑earnings commentary flagged that lower hospital patient days could pressure margins if the trend extended; investors will watch operating metrics closely in coming quarters. Will Lower Patient Days Affect Tenet Healthcare’s Q4 Earnings?

Wall Street Analyst Weigh In

A number of equities analysts have commented on THC shares. Royal Bank Of Canada lifted their target price on shares of Tenet Healthcare from $252.00 to $253.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 3rd. Guggenheim increased their target price on shares of Tenet Healthcare from $238.00 to $257.00 and gave the stock a “buy” rating in a research note on Tuesday, December 2nd. Truist Financial restated a “buy” rating and issued a $240.00 price objective (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. UBS Group reiterated a “buy” rating on shares of Tenet Healthcare in a report on Tuesday, February 3rd. Finally, Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $233.88.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of Tenet Healthcare in the fourth quarter valued at about $248,494,000. Eminence Capital LP acquired a new stake in Tenet Healthcare during the 3rd quarter worth approximately $225,263,000. Boston Partners increased its holdings in shares of Tenet Healthcare by 95.0% in the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares during the period. AQR Capital Management LLC lifted its holdings in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after purchasing an additional 720,160 shares during the period. Finally, Alliancebernstein L.P. increased its stake in Tenet Healthcare by 375.7% in the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after buying an additional 624,125 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

The company has a market cap of $19.85 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 0.82 and a beta of 1.44. The company’s 50 day moving average price is $198.00 and its 200 day moving average price is $193.90. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.